Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginInterest Coverage RatioNet MarginOperating MarginReturn on SalesTimes Interest Earned

Aethlon Medical (AEMD) Debt to Equity (2016 - 2023)

Aethlon Medical (AEMD) has disclosed Debt to Equity for 13 consecutive years, with $0.01 as the latest value for Q1 2023.

  • For the quarter ending Q1 2023, Debt to Equity rose 55.15% year-over-year to $0.01, compared with a TTM value of $0.01 through Mar 2023, up 55.15%, and an annual FY2023 reading of $0.01, up 55.15% over the prior year.
  • Debt to Equity was $0.01 for Q1 2023 at Aethlon Medical, up from $0.01 in the prior quarter.
  • Across five years, Debt to Equity topped out at $4.91 in Q3 2019 and bottomed at $0.0 in Q2 2021.
  • Average Debt to Equity over 5 years is $0.31, with a median of $0.01 recorded in 2020.
  • The sharpest move saw Debt to Equity soared 19815.5% in 2019, then plummeted 99.76% in 2020.
  • Year by year, Debt to Equity stood at $0.03 in 2019, then crashed by 60.59% to $0.01 in 2020, then plummeted by 44.96% to $0.01 in 2021, then soared by 73.76% to $0.01 in 2022, then rose by 29.06% to $0.01 in 2023.
  • Business Quant data shows Debt to Equity for AEMD at $0.01 in Q1 2023, $0.01 in Q4 2022, and $0.01 in Q3 2022.